This text first appeared in The Checkup, MIT Expertise Evaluate’s weekly biotech publication. To obtain it in your inbox each Thursday, and skim articles like this primary, join right here.

As dengue instances proceed to rise in Brazil, the nation is dealing with a large public well being disaster. The viral illness, unfold by mosquitoes, has sickened greater than one million Brazilians in 2024 alone, overwhelming hospitals.

The dengue disaster is the results of the collision of two key components. This yr has introduced an abundance of moist, heat climate, boosting populations of Aedes aegypti, the mosquitoes that unfold dengue. It additionally occurs to be a yr when all 4 varieties of dengue virus are circulating. Few folks have constructed up immunity towards all of them.   

Brazil is busy preventing again.  One of many nation’s anti-dengue methods goals to hamper the mosquitoes’ skill to unfold illness by infecting the bugs with a standard micro organism—Wolbachia. The micro organism appears to spice up the mosquitoes’ immune response, making it tougher for dengue and different viruses to develop contained in the bugs. It additionally immediately competes with viruses for essential molecules they should replicate. 

The World Mosquito Program breeds mosquitoes contaminated with Wolbachia in insectaries and releases them into communities. There they breed with wild mosquitoes. Wild females that mate with Wolbachia-infected males produce eggs that don’t hatch. Wolbachia-infected females produce offspring which can be additionally contaminated. Over time, the micro organism unfold all through the inhabitants. Final yr I visited this system’s largest insectary—a constructing in Medellín, Colombia, buzzing with hundreds of mosquitoes in netted enclosures— with a gaggle of journalists. “We’re basically vaccinating mosquitoes towards giving people illness,” mentioned Bryan Callahan, who was director of public affairs on the time.

The World Mosquito Program first started releasing Wolbachia mosquitoes in Brazil in 2014. The bugs now cowl an space with a inhabitants of greater than three million throughout 5 municipalities: Rio de Janeiro, Niterói, Belo Horizonte, Campo Grande, and Petrolina.

In Niterói, a neighborhood of about 500,000 that lies on the coast simply throughout a big bay from Rio de Janeiro, the primary small pilot releases started in 2015, and in 2017 the World Mosquito Program started bigger deployments. By 2020, Wolbachia had infiltrated the inhabitants. Prevalence of the micro organism ranged from 80% in some elements of town to 40% in others. Researchers in contrast the prevalence of viral diseases in areas the place mosquitoes had been launched with a small management zone the place they hadn’t launched any mosquitoes. Dengue instances declined by 69%. Areas with Wolbachia mosquitoes additionally skilled a 56% drop in chikungunya and a 37% discount in Zika.

How is Niterói faring in the course of the present surge? It’s early days. However the knowledge we’ve got to date are encouraging. The incidence of dengue is among the lowest within the state, with 69 confirmed instances per 100,000 folks. Rio de Janeiro, a metropolis of almost 7 million, has had greater than 42,000 instances, an incidence of 700 per 100,000.

“Niterói is the primary Brazilian metropolis we’ve got absolutely protected with our Wolbachia methodology,” says Alex Jackson, world editorial and media relations supervisor for the World Mosquito Program. “The entire metropolis is roofed by Wolbachia mosquitoes, which is why the dengue instances are dropping considerably.”

This system hopes to launch Wolbachia mosquitoes in six extra cities this summer season. However Brazil has greater than 5,000 municipalities. To make a dent within the general incidence in Brazil, this system must launch tens of millions extra mosquitoes. And that’s the plan.

The World Mosquito Program is about to begin development on a mass rearing facility—the largest on this planet—in Curitiba. “And we consider that may permit us to basically cowl most of city Brazil throughout the subsequent 10 years,” Callahan says.

There are additionally different mosquito-based approaches within the works. The UK firm Oxitec has been offering genetically modified “pleasant” mosquito eggs to Indaiatuba, Brazil, since 2018. The bugs that hatch—all males—don’t chunk. And once they mate, their feminine offspring don’t survive, lowering populations. 

One other firm, Forrest Brasil Tecnologia, has been releasing sterile male mosquitoes in elements of Ortigueira. When these males mate with wild females, they produce eggs that don’t hatch.  From November 2020 to July 2022, the corporate recorded a 98.7% decline within the Ades aegypti  inhabitants in Ortigueira. 

Brazil can also be engaged on efforts to offer its residents with larger immunity, vaccinating probably the most susceptible with a brand new shot from Japan and dealing by itself home-grown dengue vaccine. 

None of those options are a fast repair. However all of them present some hope that the world can discover methods to combat again at the same time as local weather change drives dengue and different infections to new peaks and into new territories. ““Circumstances of dengue fever are rising at an alarming charge,” Gabriela Paz-Bailey, who focuses on dengue on the US Facilities for Illness Management and Prevention, advised the Washington Publish. “It’s turning into a public well being disaster and coming to locations which have by no means had it earlier than.”

Now learn the remainder of The Checkup

Learn extra from MIT Expertise Evaluate’s archive

We’ve written concerning the World Mosquito Program earlier than. Right here’s a 2016 story from Antonio Regalado that checked out early pleasure and Invoice Gates’ backing of the mission. 

That very same yr we reported on Oxitec’s early work in Brazil utilizing genetically modified mosquitoes. Flavio Devienne Ferreira has the story. 

And this story from Emily Mullin seems to be at Google’s sister firm, Verily. It constructed a robotic to create Wolbachia-infected mosquitoes and commenced releasing them in California in 2017. (The mission is now referred to as Debug). 

From across the net

The FDA-approved ALS drug Relyvrio has failed to learn sufferers in a big scientific trial. It was permitted early amidst questions on its efficacy, and now the medication’s producer has to resolve whether or not to drag it off the  market. (NYT)

Wegovy: it’s not only for weight reduction anymore. The FDA has permitted a label enlargement that may permit Novo Nordisk to market the drug for its coronary heart advantages, which could immediate extra insurers to cowl it. (CNN)

Covid killed off one pressure of the flu and consultants counsel dropping it from the subsequent flu vaccine. (Dwell Science) 

Scientists have printed the primary research linking microplastic air pollution to human illness. The analysis exhibits that individuals with plastic of their artery tissues had been twice as prone to have a coronary heart assault, stroke, or die than folks with out plastic. (CNN)